Overview

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

Status:
Completed
Trial end date:
2018-07-03
Target enrollment:
Participant gender:
Summary
Therapeutic Equivalence of Diclofenac Sodium Gel 3% and Solaraze ®, in the treatment of Actinic Keratosis
Phase:
Phase 3
Details
Lead Sponsor:
Encube Ethicals Pvt. Ltd.
Collaborator:
Novum Pharmaceutical Research Services
Treatments:
Diclofenac